For many years, treatment of asthma has focused on symptom management and control. As the understanding of disease processes has improved and treatments begin to target underlying mechanisms, there is ...
AstraZeneca has breached the UK pharmaceutical industry's code of practice, an industry self-regulatory body ruled on Friday, ...
The study uncovers high reliance on oral corticosteroids for asthma in Italy, pointing to gaps in guideline adherence and the ...
A young woman is using an asthma inhaler outdoor An NP asks Dr Capriotti about how to get insurance to cover a budesonide-formoterol inhaler as a reliever medication for asthma attacks or ...
NICE, BTS, and SIGN guidelines: In November 2024, the National Institute for Health and Care Excellence (NICE) published the most significant update to UK guidelines in recent years. Jointly released ...
The new guidelines urge health professionals to move away from short-acting beta2 agonists (SABA) – commonly known as blue puffers – as a stand-alone treatment for adults and adolescents over the age ...
As evidenced by a debate at the CHEST Annual Meeting 2023, the pulmonology community disagrees on whether the overlap of asthma and chronic obstructive pulmonary disease (COPD) is a distinct entity ...
Two posters presented at the CHEST Annual Meeting 2023 showed how real-world exacerbation rates in asthma and chronic obstructive pulmonary disease (COPD) dropped after patients started using a single ...